Mayne Pharma Group company info

What does Mayne Pharma Group do?
Mayne Pharma (ASX:MYX) is an Australian-listed specialty pharmaceutical company focused on commercialising branded and generic pharmaceuticals. The company has a 40-year track record of innovation and success in developing new oral drug delivery systems, and it has a portfolio of over 100 commercialised products and a pipeline of over 50 products in development. Mayne Pharma's operations are focused on the commercialisation of its products in the United States and Australia, the two largest pharmaceutical markets in the world. The company also has a growing presence in other markets, such as Europe and Asia.
Mayne Pharma Group company media
Company Snapshot

Is Mayne Pharma Group a public or private company?

key
Ownership
Public

How many people does Mayne Pharma Group employ?

people
Employees
615

What sector is Mayne Pharma Group in?

pie chart
Sector
Health Care

Where is the head office for Mayne Pharma Group?

location pin
Head Office
Adelaide, Australia

What year was Mayne Pharma Group founded?

founded flag
Year Founded
2005
What does Mayne Pharma Group specialise in?
/Pharmaceutical /Medical /Healthcare /Hospital /Oncology /Drugs

What are the products and/or services of Mayne Pharma Group?

Overview of Mayne Pharma Group offerings
Commercialising a portfolio of branded and generic pharmaceuticals in multiple therapeutic areas, including women's health, oncology, dermatology, and cardiology.
Providing contract development and manufacturing services to pharmaceutical and biotechnology companies.
Developing and commercialising new branded pharmaceutical products, such as NEURONTIN (gabapentin) ER and ACTIKERALL (hydralazine).
Expanding its portfolio of generic pharmaceuticals.
Growing its contract development and manufacturing business.

Who is in the executive team of Mayne Pharma Group?

Mayne Pharma Group leadership team
  • Mr. Shawn Patrick O'Brien B.Sc
    Mr. Shawn Patrick O'Brien B.Sc
    CEO, MD & Director
  • Mr. Aaron  Gray
    Mr. Aaron Gray
    Chief Financial Officer
  • Ms. Kimberly  Parker J.D.
    Ms. Kimberly Parker J.D.
    Executive VP & General Counsel
  • Mr. Brant  Schofield
    Mr. Brant Schofield
    Executive Vice President of Corporate Development
  • Ms. Erinn  Nathaniel
    Ms. Erinn Nathaniel
    Director of Global Human Resources
  • Mr. Daniel  Moore
    Mr. Daniel Moore
    Executive Vice President of Commercial
  • Dr. Frank  Casty M.D.
    Dr. Frank Casty M.D.
    Executive VP & Global Chief Medical Officer
  • Mr. Brenton  Walter
    Mr. Brenton Walter
    Financial Controller